483 Alkermes Mar 2002

483 Alkermes Mar 2002

Kathleen Culver FDA, Mark Parmon FDA$595.00 - Available Now

FDA investigators audited the Alkermes - Wilmington, OH, United States facility and issued inspectional observations (via FDA 483) on 08 Mar 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Mar 2002
  • Location: Wilmington, United States
  • FEI: 1000142940
Add To Cart